Scripps Diabetes Researcher Presents Weekly Insulin Study Results
Scripps Whittier Institute for Diabetes plays lead role in testing experimental therapy
![A man holding a bottle of insulin with a syringe also in his hand, illustrating a diabetic patient administering insulin.](http://www.scripps.org/sparkle-assets/images/bottle-of-insulin-1d7e6ac5ee3bbb6c2f7a96b3ebaaa6de.jpg)
Scripps Whittier Institute for Diabetes plays lead role in testing experimental therapy
Scripps Whittier Institute for Diabetes’ leading role in the global effort to develop long-acting insulin was on full display recently when the institute’s corporate vice president, Athena Philis-Tsimikas, MD, presented encouraging clinical trial results at a major medical conference in Stockholm.
Dr. Philis-Tsimikas was a lead investigator in the study that compared an experimental weekly insulin shot to the more typical one-a-day insulin shot in patients with type 2 diabetes.
Watch the 10News report: Scripps Health Study Could Drasticaally Cut Insulin Shots From Once a Day to Once a Week
Read the San Diego Union-Tribune article: Once-Per-Week Insulin Shots? New Research by Scripps Doctor Showing Promise
Read the BioSpace article: Novo’s Once-Weekly Insulin Treatment Part of a Transforming T2D Space
Media Contact
- Keith Darce
- 858-678-7121
- darce.keith@scrippshealth.org
- Follow me: @KeithDarce